Learn More
JASVINDER A. SINGH, DANIEL E. FURST, ASEEM BHARAT, JEFFREY R. CURTIS, ARTHUR F. KAVANAUGH, JOEL M. KREMER, LARRY W. MORELAND, JAMES O’DELL, KEVIN L. WINTHROP, TIMOTHY BEUKELMAN, S. LOUIS BRIDGES JR.,(More)
BACKGROUND 12 months of oral cyclophosphamide has been shown to alter the progression of scleroderma-related interstitial lung disease when compared with placebo. However, toxicity was a concern and(More)